Protective effect of hydralazine on a cellular model of Parkinson’s disease: a possible role of hypoxia-inducible factor (HIF)-1α
Biochemistry and Cell Biology · 2020-06 · 98 (3) · 405-414
DOI: 10.1139/bcb-2019-0117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry and Cell Biology, 2020-06. Verfasst von Mehrnaz Mehrabani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Physiology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a neurodegenerative disease accompanied by a low expression level of cerebral hypoxia-inducible factor (HIF-1α). Hence, activating the hypoxia-signaling pathway may be a favorable therapeutic approach for curing PD. This study explored the efficacy of hydralazine, a well-known antihypertensive agent, for restoring the impaired HIF-1 signaling in PD, with the aid of 6-hydroxydopamine (6-OHDA)-exposed SH-SY5Y cells. The cytotoxicity of hydralazine and 6-OHDA on the SH-SY5Y cells were evaluated by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] and apoptosis detection assays. The activities of malondialdehyde, nitric oxide (NO), ferric reducing antioxidant power (FRAP), and superoxide dismutase (SOD) were also measured. Expression levels of HIF-1α and its downstream genes at the protein level were assessed by Western blotting. Hydralazine showed no toxic effects on SH-SY5Y cells, at the concentration of ≤50 μmol/L. Hydralazine decreased the levels of apoptosis, malondialdehyde, and NO, and increased the activities of FRAP and SOD in cells exposed to 6-OHDA. Furthermore, hydralazine up-regulated the protein expression levels of HIF-1α, vascular endothelial growth factor, tyrosine hydroxylase, and dopamine transporter in the cells also exposed to 6-OHDA, by comparison with the cells exposed to 6-OHDA alone. In summary, hydralazine priming could attenuate the deleterious effects of 6-OHDA on SH-SY5Y cells by increasing cellular antioxidant capacity, as well as the protein levels of HIF-1α and its downstream target genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Physiology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.
- Kerman Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
- Department of Biochemistry, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
- Cardiovascular research center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.
- Department of Pharmacology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
- Student Research Committee, Kerman University Medical Sciences, Kerman, Iran.
Zitieren
APA
Mehrabani, M., Nematollahi, M. H., Tarzi, M. E., Juybari, K. B., Abolhassani, M., Sharifi, A. M., Paseban, H., Saravani, M., & Mirzamohammadi, S. (2020). Protective effect of hydralazine on a cellular model of Parkinson’s disease: a possible role of hypoxia-inducible factor (HIF)-1α. Biochemistry and Cell Biology, 98(3), 405-414. https://doi.org/10.1139/bcb-2019-0117
Vancouver
Mehrabani M, Nematollahi MH, Tarzi ME, Juybari KB, Abolhassani M, Sharifi AM, et al. Protective effect of hydralazine on a cellular model of Parkinson’s disease: a possible role of hypoxia-inducible factor (HIF)-1α. Biochemistry and Cell Biology. 2020;98(3):405-414. doi:10.1139/bcb-2019-0117
BibTeX
@article{Mehrabani2020,
author = {Mehrabani, Mehrnaz and Nematollahi, Mohammad Hadi and Tarzi, Mojde Esmaeili and Juybari, Kobra Bahrampour and Abolhassani, Moslem and Sharifi, Ali Mohammad and Paseban, Hamze and Saravani, Mohsen and Mirzamohammadi, Solmaz},
title = {Protective effect of hydralazine on a cellular model of Parkinson’s disease: a possible role of hypoxia-inducible factor (HIF)-1α},
journal = {Biochemistry and Cell Biology},
year = {2020},
volume = {98},
number = {3},
pages = {405--414},
doi = {10.1139/bcb-2019-0117}
}
EUVIMED